Stock Price
29.22
Daily Change
0.06 0.21%
Monthly
7.03%
Yearly
33.67%
Q1 Forecast
27.75

Galapagos reported EUR-0.41 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -0.17 0.29 Feb/24 2026
FY2025Q3 Sep/2025 -3.07 -0.41 -0.74 Nov/05 2025
FY2025Q1 Jun/2025 -1.58 -0.17 0.11 Jul/23 2025
FY2025Q1 Mar/2025 -2.35 -0.16 0.36 Apr/23 2025
FY2024Q4 Dec/2024 0.29 -0.36 2.39 Feb/12 2025




Eps Change Date
argenx SE USD 4.44 1.18 Sep/2025
AstraZeneca USD 2.38 0.21 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
Genmab DKK 34.31 14.07 Jun/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.55 0.08 Sep/2025
GRIFOLS EUR 0.21 0.02 Sep/2025
Hikma Pharmaceutical USD 0.54 0.06 Jun/2025
Incyte USD 2.26 0.69 Sep/2025
Merck EUR 2.32 0.56 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
UCB EUR 2.44 0.45 Jun/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025